Kliniken des Landkreises Lörrach GmbH
Hospital
Location:
Lörrach, Rheinfelden, Schopfheim,
Germany (DE)
ISNI: 0000000405595197
ROR: https://ror.org/0229ja564
Show on Map:
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)+ (2014)
Von Minckwitz G, Loibl S, Untch M, Eidtmann H, Rezai M, Fasching P, Tesch H, et al.
Journal article
Surgical outcome after neoadjuvant chemotherapy and bevacizumab: results from the GeparQuinto study (GBG 44) (2014)
Gerber B, Von Minckwitz G, Eidtmann H, Rezai M, Fasching P, Tesch H, Eggemann H, et al.
Journal article
Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial (2010)
Witzel I, Loibl S, Von Minckwitz G, Mundhenke C, Huober J, Hanusch C, Henschen S, et al.
Journal article